Company Overview of Nucleonics, Inc.
Nucleonics, Inc. develops RNAi therapeutics for viral and other diseases. It offers NUC-B1000, a hepatitis B antiviral agent. The company also focuses on the development of eiRNA-based therapeutics for chronic hepatitis B and hepatitis C infections. Nucleonics, Inc. was founded in 2001 and is based in Langhorne, Pennsylvania.
13 Summit Square Center
Langhorne, PA 19047-1098
Founded in 2001
Key Executives for Nucleonics, Inc.
Similar Private Companies By Industry
|Tocagen Inc.||United States|
|A/F Protein Inc.||United States|
|Genprex, Inc.||United States|
|PhyNexus Inc.||United States|
|American Centrality Group, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Nucleonics, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.